Firm misled investors on Alzheimer’s drug, SEC charges

Authors

Publication Details

Journal
Science
Published
2024-10-03
DOI
https://doi.org/10.1126/science.adt5694
Citations
2
Primary Topic
Biotechnology and Related Fields
Type
article
Field-Weighted Citation Impact
1.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Firm misled investors on Alzheimer’s drug, SEC charges

Charles Piller
2 citations
Science
Biotechnology and Related Fields
1.09
article

Firm misled investors on Alzheimer’s drug, SEC charges

Charles Piller
article en
2 citations

Abstract

No abstract available for this paper.
ScienceVol. 386(6717)
Openalex Percentile: Top 20%
Biotechnology and Related Fields
1.09
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Firm misled investors on Alzheimer’s drug, SEC charges — Charles Piller · Science (2024) | TGRS Research Map | TGRS